期刊文献+

肝癌的细胞凋亡及其紫杉醇的诱导作用研究 被引量:4

Study of apoptosis in liver cancer and the induction by taxol.
下载PDF
导出
摘要 目的研究肝癌发生过程中原位细胞凋亡活动以及紫杉醇对肝癌细胞系BEL-7404诱导细胞凋亡的作用。方法用脱氧核糖核酸末端转移酶介导的缺口末端标记法检测了肝细胞癌的细胞凋亡,用紫杉醇处理培养细胞BEL-7404、显微镜下进行观察并且进行琼脂糖电泳。结果癌旁组织的原位凋亡细胞增多,紫杉醇处理肝癌细胞可以诱导细胞产生典型的细胞凋亡形态学变化。DNA发生断裂,琼脂糖电泳产生梯形条带。结论在体内肿瘤细胞凋亡降低,细胞分裂可能加快,肿瘤发生。在癌旁组织中细胞凋亡增多,在体外紫杉醇可以诱导肝癌细胞系BEL-7404凋亡。 In order to investigate the action of in situ apoptosis in occurrence of liver carcinomas and the biological effect of taxol on BEL - 7404 cell line inducing apoptosis, Methods- The apoptosis in the hepatoceluller carcinomas was detected with terminal deoxynucl neotidyl transferase mediated dUTP nick end labelling (TUNEL) ; the BEL -7404 cell line cultured in DMED medium were treated with taxol and observed under microscope, and their DNA was assayed by gel electrophoresis. Results: In situ apoptotic cells in the cancer adjacent tissues inceased; treatment of liver cancers with taxol could induce the cells to manifest a typical apoptotic morphology. Their DNA was fractured and a characteristic ladder pattern could be found using electrophoresis. Conclusion: In vivo the apoptosis of carcinomas was lower; maybe the cells divided quickly and then the cancers occurred. In the cancer adjacent tissues. the anontosis nricked un. and in vitro taxol could induce the apoptosis of BEL -7404 cells.
作者 李娟 单长民
出处 《中国优生与遗传杂志》 2007年第2期21-22,63,共3页 Chinese Journal of Birth Health & Heredity
关键词 肝癌 细胞凋亡 紫杉醇 Liver cancer Taxol Apoptosis
  • 相关文献

参考文献10

  • 1Park YN,Chae KJ,Kim YB,Park C,Theise N.Apoptosis and proliferation in hepatocarcinogenesis related to cirrhosis[J].Cancer,2001,92(11):2733 -2738.
  • 2Wyllie A H,Apoptosis.Death gets a brake[J].Nature,1994,369(6478):272-273.
  • 3彭晓谋,彭文伟,陈青,姚集鲁.肝细胞癌P53,Bcl-2蛋白的表达和细胞凋亡[J].华人消化杂志,1998,6(10):834-836. 被引量:15
  • 4Bold R J,Virudachalam S,McConkey DJ.BCL2 expression correlates with metastatic potential in pancreatic cancer cell lines[J].Cancer,2001,92:1122-1129.
  • 5王立权,许兰文,周光兴,周文江,杨萍,乔伟伟.紫杉醇对人SMMC-7721肝癌细胞增殖和荷瘤裸小鼠肿瘤生长抑制作用[J].上海实验动物科学,2004,24(1):43-45. 被引量:6
  • 6谢聪颖,吴式,张萍.紫杉醇联合草酸铂治疗复治晚期非小细胞肺癌的疗效[J].癌症,2004,23(8):947-950. 被引量:16
  • 7Luo D,Cheng SCS,Xie Yong.Expression of bc1-2 family proteins during chemotherapeutic agents-induced apoptosis in the hepatoblastoma HepG2 cell line[J].Br J Biomed Sci,1999,56:114-118.
  • 8Ricotti L,Tesei A,De Paola F,Milandri C,Amadori D,Frassineti GL,Ulivi P,Zoli W.Potentiation of antiproliferative drug activity by onidamine in hepatocellular carcinoma cells[J].J Chemother,2003,15 (5):480 -487.
  • 9Chan KT,Lung ML.Mutant p53 expression enhances drug resistance in a hepatocellular carcinoma cell line[J].Cancer Chemother Pharmacol.2004,53(6):519 -26.
  • 10Sutter AP,Maaser K,Grabowski P,Bradacs G,Vormbrock K,Hopfner M,Krahn A,Heine B,Stein H,Somasundaram R,Schuppan D,Zeitz M,Scherubl H.Peripheral benzodiazepine receptor ligands induce apoptosis and cell cycle arrest in human hepatocellular carcinoma cells and enhance chemosensitivity to paclitaxel,docetaxel,doxorubicin and the Bcl-2 inhibitor HA14-1[J].J Hepatol,2004,41 (5):799-807.

二级参考文献10

  • 1Raymond E,Chaney SG,Taamma A,et al. Oxaliplatin: a review of preclinical and clinical studies [J]. Ann Oncol,1998,9(10):1053- 1071.
  • 2Rixe O,Ortuzar W,Alvarez M,et al. Oxaliplatin, tetraplatin, cisplatin, and carboplatin: spectrum of activity in drug resistant cell lines and in the cell lines of the national cancer institute's anticancer drug screen panel [J]. Biochem Pharmacol,1996,52(12):1855- 1859.
  • 3Monnet I,Brienza S,Hugret F,et al. Phase Ⅱ study of oxaliplatin in poor-prognosis non-small cell lung cancer (NSCLC). AT-TIT. Association pour le Traitement des Tumeurs Intra Thoraciques [J]. Eur J Cancer,1998, 34(7):1124- 1127.
  • 4Faivre S,Kalla S,Cvitkovic E,et al. Oxaliplatin and paclitaxel combination in patients with platinum-pretreated ovarian carcinoma:an investigator-originated compassionate-use experience [J]. Ann Oncol,1999, 10(9):1125- 1128.
  • 5Jamieson SM,Liu J,Hsu T,et al. Paclitaxel induces nuckeolar enlargement in dorsal root ganglion neurons in vivo reducing oxaliplatin toxicity [J]. Br J Cancer,2003, 88(12):1942- 1947.
  • 6Liu J,Kraut EH,Balcerzak S,et al. Dosing sequence-dependent pharmacokinetic interaction of oxaliplatin with paclitaxel in the rat [J]. Cancer Chemother Pharmacol,2002, 50(6):445- 453.
  • 7苏庆光,孙冲涛.奥沙利铂的不良反应[J].药物流行病学杂志,1999,8(3):157-159. 被引量:23
  • 8袁金辉,郭立霞,王兴旺,谢弘.紫杉醇的最新研究进展[J].中国药理学通报,2001,17(2):135-139. 被引量:20
  • 9贾永庆,吴军正,刘斌,李峰,李焰,李洁.Docetaxel对涎腺粘液表皮样癌高转移细胞增殖及转移力的抑制作用[J].实用口腔医学杂志,2002,18(2):114-116. 被引量:11
  • 10张湘茹.非小细胞肺癌二线化疗现状[J].中国肺癌杂志,2002,5(5):389-392. 被引量:7

共引文献34

同被引文献24

引证文献4

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部